Bushu Pharmaceuticals

Kawagoe, Saitama, Japan
Oral Solid Dose Sterile Injectables Clinical Trial Manufacturing Packaging & Labeling
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
✓ FDA Inspections (3) ○ Clinical Trials ○ SEC Filings ○ Press ○ EMA GMP ○ MHRA GMP

Quick Facts: Bushu Pharmaceuticals

Signal Score
Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
Headquarters
Kawagoe, Saitama, Japan
Website
Modalities
Oral Solid Dose, Sterile Injectables, Clinical Trial Manufacturing, Packaging & Labeling
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring

About Bushu Pharmaceuticals

Bushu Pharmaceuticals is a contract development and manufacturing organization (CDMO). Capabilities: Oral Solid Dose, Sterile Injectables, Clinical Trial Manufacturing, Packaging & Labeling. 2 manufacturing sites registered with the U.S. FDA and Health Canada. Website: https://www.bushu-pharma.com/en/

Signal Score

Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works

Bushu Pharmaceuticals FDA Inspection History

2026-08
2023-11
2022-12
NAI VAI OAI
Date Site Type Observations Classification
2026-08-03
Bushu Pharmaceuticals Ltd.
Kawagoe Company-level
Drug Quality Assurance Yes Voluntary Action Indicated (VAI)
2023-11-10
Bushu Pharmaceuticals Ltd
Kodama-Gun Company-level
Drug Quality Assurance No No Action Indicated (NAI)
2022-12-02
Bushu Pharmaceuticals Ltd.
Kawagoe Company-level
Drug Quality Assurance Yes Voluntary Action Indicated (VAI)
Source: FDA Data Dashboard · Retrieved Oct 31, 2026

Bushu Pharmaceuticals FDA 483 Findings 5 observations · 2022-12-02 → 2026-08-03 ?

By subsystem

  • Laboratory Controls 2 (40.0%)
  • Documentation & Records 2 (40.0%)
  • Other 1 (20.0%)

By severity

  • 3 — Moderate: 2
  • 2 — Minor: 3
  • Repeat observations: 0

Most severe findings

  • Moderate (3) Laboratory Controls 2026-08-03 21 CFR 211.194(a)
    Complete test data included in records

    "Laboratory records do not include complete data derived from all tests, examinations and assay necessary to assure compliance with established specifications and standards."

  • Moderate (3) Laboratory Controls 2022-12-02 21 CFR 211.160(a)
    Following/documenting laboratory controls

    "Established test procedures and laboratory control mechanisms are not followed and documented at the time of performance."

  • Minor (2) Documentation & Records 2026-08-03 21 CFR 211.110(a)
    Written in-process control procedures

    "Written procedures are not established that describe the in-process controls to be conducted on appropriate samples of in-process materials of each batch."

Hiring Activity Beta

Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data. This company's careers site asks automated readers not to collect it (robots.txt), and we respect that.
Source: public careers pages · Checked Oct 30, 2026

Frequently Asked Questions About Bushu Pharmaceuticals

How many FDA inspections does Bushu Pharmaceuticals have on record?
CDMO Signal tracks 3 FDA inspections for Bushu Pharmaceuticals, sourced from the FDA inspection database. See the full inspection history above.
Has Bushu Pharmaceuticals received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Bushu Pharmaceuticals.
Does Bushu Pharmaceuticals have a CDMO Signal Score?
Not yet. Bushu Pharmaceuticals is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Bushu Pharmaceuticals for a manufacturing program?
Use the free AI matchmaker to compare Bushu Pharmaceuticals against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.

Similar CDMOs

Shionogi Pharma
Settsu, Osaka, Japan
Small Molecule API, High-Potency APIs, Oral Solid Dose, Packaging & Labeling, Clinical Trial Manufacturing
PCI Pharma Services
Bedford, NH, United States · Tredegar, United Kingdom
Sterile Fill-Finish, Biologics, Oral Solid Dose, Clinical Trial Manufacturing, Packaging & Labeling
IBI Lorenzini
Aprilia, Latina, Italy
Sterile Injectables, Lyophilization, Biologics, Oral Solid Dose, Topicals, Clinical Trial Manufacturing
Reig Jofre CDMO
Sant Joan Despí, Barcelona, Spain
Sterile Injectables, Lyophilization, Oral Solid Dose, Non-sterile Liquids, Clinical Trial Manufacturing
DMX Pharma
Milan, Italy
Oral Solid Dose, Oral Liquids, Semi-solids & Liquids, Softgels, Sterile Injectables, Inhalation & Nasal, Packaging & Labeling

Compare Bushu Pharmaceuticals with another CDMO

Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Get updates on Bushu Pharmaceuticals
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.